All Stories

  1. Romina: A powerful strawberry with in vitro efficacy against uterine leiomyoma cells
  2. Molecular Aspects of Adipoepithelial Transdifferentiation in Mouse Mammary Gland
  3. Ulipristal Acetate Modulates the Expression and Functions of Activin A in Leiomyoma Cells
  4. Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells
  5. Management of leiomyomas in perimenopausal women
  6. IL-1β and TGF-β weaken the placental barrier through destruction of tight junctions: An in vivo and in vitro study
  7. Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: Promising options for prevention and treatment of uterine fibroids?
  8. Role of Activin-A and Myostatin and Their Signaling Pathway in Human Myometrial and Leiomyoma Cell Function
  9. Complex networks of multiple factors in the pathogenesis of uterine leiomyoma
  10. Uterine Leiomyoma: Available Medical Treatments and New Possible Therapeutic Options
  11. Pathogenesis of Endometriosis and Uterine Fibroids
  12. Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction
  13. RKIP and cytotrophoblast motility
  14. Placental Expression of CD100, CD72 and CD45 Is Dysregulated in Human Miscarriage
  15. Possible role of RKIP in cytotrophoblast migration: immunohistochemical and in vitro studies
  16. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications
  17. Activin-A and Myostatin Response and Steroid Regulation in Human Myometrium: Disruption of Their Signaling in Uterine Fibroid
  18. Activin-A and Myostatin Response and Steroid Regulation in Human Myometrium: Disruption of Their Signalling in Uterine Fibroid
  19. Activating protein-1 family of transcription factors in the human placenta complicated by preeclampsia with and without fetal growth restriction
  20. Polymorphisms of FAS and FAS ligand genes in preeclamptic women
  21. Differential expression of follistatin and FLRG in human breast proliferative disorders
  22. Presence, Actions, and Regulation of Myostatin in Rat Uterus and Myometrial Cells
  23. Activin-A in Myometrium: Characterization of the Actions on Myometrial Cells
  24. Human placenta and fetal membranes express nerve growth factor mRNA and protein
  25. Mutational analysis of the inhibin alpha gene in preeclamptic women
  26. Inhibin  -subunit and the inhibin coreceptor betaglycan are downregulated in endometrial carcinoma
  27. Inhibins and activins in pregnancy
  28. Follistatin-related gene expression, but not follistatin expression, is decreased in human endometrial adenocarcinoma
  29. Human endometrium and decidua express follistatin-related gene (FLRG) mRNA and peptide
  30. Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A
  31. Expression of betaglycan in pregnant tIssues throughout gestation
  32. High Levels of Intrauterine Corticotrophin-Releasing Hormone, Urocortin, Tryptase, and Interleukin-8 in Spontaneous Abortions
  33. Human placenta and fetal membranes express follistatin-related gene mRNA and protein
  34. Endometrial Expression and Secretion of Activin A, But Not Follistatin, Increase in the Secretory Phase of the Menstrual Cycle
  35. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels
  36. Structural Analysis of the rDNA Intergenic Spacer of Tuber Borchii
  37. PCR amplification and polymorphism analysis of the intergenic spacer region of ribosomal DNA in Tuber borchii
  38. Placental Stress Factors and Maternal-Fetal Adaptive Response : The Corticotropin-Releasing Factor Family
  39. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels
  40. Changes in inhibins and activin secretion in healthy and pathological pregnancies